The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) is a prominent research institution based in Heidelberg, Germany, founded in 1964. It operates within the manufacturing sector, specifically focusing on pharmaceuticals. With an employee size ranging from 201 to 500, DKFZ reported a revenue of approximately 321.7 million USD. The center is actively involved in cancer research and public health initiatives, particularly in tobacco control, as evidenced by its recent publication, the "Tobacco Industry Interference Index Germany 2023." This document discusses the influence of the tobacco industry on public health policy and highlights key findings and recommendations for mitigating such interference. The DKFZ collaborates with various organizations and stakeholders to promote cancer prevention and control efforts, and it serves as a World Health Organization Collaborating Centre for Tobacco Control. The center's work emphasizes the importance of transparency and accountability in addressing public health challenges related to tobacco use.